Life Sciences

Following a loss of more than $4 billion in 2012, Natick-based Boston Scientific continued to see declining revenue and profits in its first quarter of 2013.

The Massachusetts Life Sciences Center has launched a new program for Massachusetts companies to partner with international firms.

Waltham-based Thermo Fisher Scientific, which has facilities in Franklin and Milford, will grow by nearly a third early next year when it acquires a California-based biotechnology manufacturer for $13.6 billion. The intended purchase of Life Technologies is Thermo's largest deal since 2006 and is expected to increase its position in the DNA sequencing market. The deal is expected to close early next year.

The recent release of the Boston Foundation's report on Massachusetts' $1-billion, 10-year life sciences initiative revealed that...

Holliston-based Harvard Bioscience (HBIO) said it will delay an initial public offering of its subsidiary, Harvard Apparatus Regenerative Technology (HART), because of market conditions.

French pharmaceutical company Ipsen and its Cambridge-based partner, Inspiration Biopharmaceuticals, have closed a a deal to sell...

At a public cost of more than $22,000 per job, tax incentives authorized under a 2008 law to grow the Massachusetts life sciences sector created more than 2,500 jobs through June 2012, according to a report released Tuesday.

Framingham-based Boston Heart Diagnostics, which makes proprietary tests for the treatment of cardiovascular disease, has received $450,000 in state tax credits and promised to create 35 new jobs this year.

Natick-based Boston Scientific Corp. (BSX) has been accused of poaching employees from its competitor, Abbott Laboratories, in...

Medical device manufacturer HeartWare International of Framingham has completed the public offering of 1.725 million shares of common stock that it filed with the U.S. Securities and Exchange Commission in December 2010, the company announced.